| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Dr. Jemal is Program Director, Cancer Occurrence, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Tiwari is Mathematical Statistician, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Mr. Murray is Manager, Surveillance Data Systems, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Ghafoor is Epidemiologist, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Ms. Samuels is Manager, Surveillance Information Services, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Ward is Director, Surveillance Research, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Dr. Feuer is Branch Chief, Statistical Research and Applications Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
Dr. Thun is Vice-President, Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, GA.
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival rates based on incidence data from the National Cancer Institute and mortality data from the National Center for Health Statistics. Incidence and mortality rates are age standardized to the 2000 US standard million population. A total of 1,368,030 new cancer cases and 563,700 deaths are expected in the United States in 2004. Incidence rates stabilized among men from 1995 through 2000 but continued to increase among females by 0.4% per year from 1987 through 2000. Mortality rates have decreased by 1.5% per year since 1992 among men, but have stabilized from 1998 through 2000 among women. Cancer death rates continued to decrease from the three major cancer sites in men (lung and bronchus, colon and rectum, and prostate) and from female breast and colorectal cancers in women. In analyses by race and ethnicity, African-American men and women have 40% and 20% higher death rates from all cancers combined compared with White men and women, respectively. Cancer incidence and mortality rates are lower in other racial and ethnic groups than in Whites and African Americans for all sites combined and for the four major cancer sites. However, these groups generally have higher rates for stomach, liver, and cervical cancers than do Whites. Furthermore, minority populations are more likely to be diagnosed with advanced stage disease than are Whites. Progress in reducing the burden from cancer can be accelerated by applying existing cancer control knowledge into practice among all segments of the population.
This article has been cited by other articles:
|
|
 |
|
  H. R. Qin, H.-J. Kim, J.-Y. Kim, E. M. Hurt, G. J. Klarmann, B. T. Kawasaki, M. A. Duhagon Serrat, and W. L. Farrar Activation of Signal Transducer and Activator of Transcription 3 through a Phosphomimetic Serine 727 Promotes Prostate Tumorigenesis Independent of Tyrosine 705 Phosphorylation Cancer Res., October 1, 2008; 68(19): 7736 - 7741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Bailey, B. J. Swanson, T. Hamada, J. P. Eggers, P. K. Singh, T. Caffery, M. M. Ouellette, and M. A. Hollingsworth Sonic Hedgehog Promotes Desmoplasia in Pancreatic Cancer Clin. Cancer Res., October 1, 2008; 14(19): 5995 - 6004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sakashita, K. Mimori, F. Tanaka, Y. Kamohara, H. Inoue, T. Sawada, K. Hirakawa, and M. Mori Prognostic Relevance of Tensin4 Expression in Human Gastric Cancer Ann. Surg. Oncol., September 1, 2008; 15(9): 2606 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Knab, J. K. Salama, A. Solanki, K. M. Stenson, E. E. Cohen, M. E. Witt, D. J. Haraf, and E. E. Vokes Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinoma Ann. Onc., September 1, 2008; 19(9): 1650 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Eiblmaier, L. A. Meyer, M. A. Watson, P. M. Fracasso, L. J. Pike, and C. J. Anderson Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines J. Nucl. Med., September 1, 2008; 49(9): 1472 - 1479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A Gilchrest Sun exposure and vitamin D sufficiency Am. J. Clinical Nutrition, August 1, 2008; 88(2): 570S - 577S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakashita, K. Mimori, F. Tanaka, Y. Kamohara, H. Inoue, T. Sawada, K. Hirakawa, and M. Mori Clinical Significance of Loss of Fhl1 Expression in Human Gastric Cancer Ann. Surg. Oncol., August 1, 2008; 15(8): 2293 - 2300. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Pitari, J. E. Lin, F. J. Shah, W. J. Lubbe, D. S. Zuzga, P. Li, S. Schulz, and S. A. Waldman Enterotoxin preconditioning restores calcium-sensing receptor-mediated cytostasis in colon cancer cells Carcinogenesis, August 1, 2008; 29(8): 1601 - 1607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Masciullo, E. Berardengo, A. Boglione, A. Sgambato, A. Bernardi, M. Forni, A. Linari, L. Cito, G. Scambia, A. Comandone, et al. The Retinoblastoma Family Member pRb2/p130 Is an Independent Predictor of Survival in Human Soft Tissue Sarcomas Clin. Cancer Res., August 1, 2008; 14(15): 4775 - 4779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lu, H. Xiao, H. You, Y. Lin, H. Jin, B. Snagaski, and C. S. Yang Synergistic Inhibition of Lung Tumorigenesis by a Combination of Green Tea Polyphenols and Atorvastatin Clin. Cancer Res., August 1, 2008; 14(15): 4981 - 4988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Summers, L. R. Handwerker, P. J. Pickhardt, R. L. Van Uitert, K. K. Deshpande, S. Yeshwant, J. Yao, and M. Franaszek Performance of a Previously Validated CT Colonography Computer-Aided Detection System in a New Patient Population Am. J. Roentgenol., July 1, 2008; 191(1): 168 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Psyrri, P. Kountourakis, A. Scorilas, S. Markakis, R. Camp, D. Kowalski, E. P. Diamandis, and M. A. Dimopoulos Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression Ann. Onc., July 1, 2008; 19(7): 1271 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Placencio, A.-R. Sharif-Afshar, X. Li, H. Huang, C. Uwamariya, E. G. Neilson, M. M. Shen, R. J. Matusik, S. W. Hayward, and N. A. Bhowmick Stromal Transforming Growth Factor-{beta} Signaling Mediates Prostatic Response to Androgen Ablation by Paracrine Wnt Activity Cancer Res., June 15, 2008; 68(12): 4709 - 4718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ralhan, L. V. DeSouza, A. Matta, S. Chandra Tripathi, S. Ghanny, S. Datta Gupta, S. Bahadur, and K. W. M. Siu Discovery and Verification of Head-and-neck Cancer Biomarkers by Differential Protein Expression Analysis Using iTRAQ Labeling, Multidimensional Liquid Chromatography, and Tandem Mass Spectrometry Mol. Cell. Proteomics, June 1, 2008; 7(6): 1162 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kitajima, K. Murakami, E. Yamasaki, I. Fukasawa, N. Inaba, Y. Kaji, and K. Sugimura Accuracy of 18F-FDG PET/CT in Detecting Pelvic and Paraaortic Lymph Node Metastasis in Patients with Endometrial Cancer Am. J. Roentgenol., June 1, 2008; 190(6): 1652 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. McFall, J. Ureda, T. L. Byrd, A. Valdes, P. Morales, D. B. Scott, D. Williams, J. Calderon-Mora, M. E. Casillas, and E. C. Y. Chan What is needed for informed decisions about prostate cancer screening: perspectives of African-American and Hispanic men Health Educ. Res., May 9, 2008; (2008) cyn018v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vicent, D. Luis-Ravelo, I. Anton, I. Garcia-Tunon, F. Borras-Cuesta, J. Dotor, J. De Las Rivas, and F. Lecanda A Novel Lung Cancer Signature Mediates Metastatic Bone Colonization by a Dual Mechanism Cancer Res., April 1, 2008; 68(7): 2275 - 2285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Cotton, M. K. O'Bryan, and B. T. Hinton Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction Endocr. Rev., April 1, 2008; 29(2): 193 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Takei, Y. Saga, H. Mizukami, T. Takayama, M. Ohwada, K. Ozawa, and M. Suzuki Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice Mol. Cancer Ther., March 1, 2008; 7(3): 704 - 711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Fletcher, B. Djulbegovic, H. P. Soares, B. A. Siegel, V. J. Lowe, G. H. Lyman, R. E. Coleman, R. Wahl, J. C. Paschold, N. Avril, et al. Recommendations on the Use of 18F-FDG PET in Oncology J. Nucl. Med., March 1, 2008; 49(3): 480 - 508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Steinert, M. Hantschick, M. Vieth, I. Gastinger, F. Kuhnel, H. Lippert, and M. A. Reymond Influence of Subclinical Tumor Spreading on Survival After Curative Surgery for Colorectal Cancer Arch Surg, February 1, 2008; 143(2): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Dubinsky, C. Cuevas, M. K. Dighe, O. Kolokythas, and J. H. Hwang High-Intensity Focused Ultrasound: Current Potential and Oncologic Applications Am. J. Roentgenol., January 1, 2008; 190(1): 191 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Shah, J. M. Summy, J. Zhang, S. I. Park, N. U. Parikh, and G. E. Gallick Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells Ann. Surg. Oncol., December 1, 2007; 14(12): 3629 - 3637. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H. Pharo Optimizing Living With Cancer Pain J Am Osteopath Assoc, December 1, 2007; 107(suppl_7): ES1 - ES2. [Full Text] [PDF]
|
|
|
|
|
|
D. -W. Kim, S. -Y. Kim, H. -K. Kim, S. -W. Kim, S. W. Shin, J. S. Kim, K. Park, M. Y. Lee, and D. S. Heo Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann. Onc., December 1, 2007; 18(12): 2009 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Gallagher, M. Capanu, G. Raggio, and N. Kemeny Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: a retrospective analysis Ann. Onc., December 1, 2007; 18(12): 1995 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Pharo and L. Zhou Controlling Cancer Pain With Pharmacotherapy J Am Osteopath Assoc, December 1, 2007; 107(suppl_7): ES22 - ES32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Li, J. E. Lin, I. Chervoneva, S. Schulz, S. A. Waldman, and G. M. Pitari Homeostatic Control of the Crypt-Villus Axis by the Bacterial Enterotoxin Receptor Guanylyl Cyclase C Restricts the Proliferating Compartment in Intestine Am. J. Pathol., December 1, 2007; 171(6): 1847 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Boller and H. Nelson Colon and Rectal Cancer: Laparoscopic or Open? Clin. Cancer Res., November 15, 2007; 13(22): 6894s - 6896s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Monin, M. Monchi, M. E.W. Kirsch, H. Petit-Eisenmann, S. Baleynaud, C. Chauvel, D. Metz, C. Adams, J.-P. Quere, P. Gueret, et al. Low-gradient aortic stenosis: impact of prosthesis-patient mismatch on survival Eur. Heart J., November 1, 2007; 28(21): 2620 - 2626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, H. G. Vikis, Y. Yi, M. Futamura, Y. Wang, and M. You Degradation of Lung Adenoma Susceptibility 1, a Major Candidate Mouse Lung Tumor Modifier, Is Required for Cell Cycle Progression Cancer Res., November 1, 2007; 67(21): 10207 - 10213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Kulasingam and E. P. Diamandis Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines: A Mine for Biomarkers and Therapeutic Targets Mol. Cell. Proteomics, November 1, 2007; 6(11): 1997 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. N. Kolar, R. Barhoumi, E. S. Callaway, Y.-Y. Fan, N. Wang, J. R. Lupton, and R. S. Chapkin Synergy between docosahexaenoic acid and butyrate elicits p53-independent apoptosis via mitochondrial Ca2+ accumulation in colonocytes Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G935 - G943. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Oudard, E. Banu, F. Scotte, A. Banu, J. Medioni, P. Beuzeboc, F. Joly, J.-M. Ferrero, F. Goldwasser, and J.-M. Andrieu Prostate-specific antigen doubling time before onset of chemotherapy as a predictor of survival for hormone-refractory prostate cancer patients Ann. Onc., November 1, 2007; 18(11): 1828 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Mueller, F. A. Goumas, M. Affeldt, S. Sandtner, U. M. Gehling, S. Brilloff, J. Walter, N. Karnatz, K. Lamszus, X. Rogiers, et al. Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment Am. J. Pathol., November 1, 2007; 171(5): 1608 - 1618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lyshchik, S. B. Hobbs, A. C. Fleischer, D. Khabele, D.-S. Son, J. C. Gore, and R. R. Price Ovarian Volume Measurements in Mice With High-Resolution Ultrasonography J. Ultrasound Med., October 1, 2007; 26(10): 1419 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lapointe, C. Li, C. P. Giacomini, K. Salari, S. Huang, P. Wang, M. Ferrari, T. Hernandez-Boussard, J. D. Brooks, and J. R. Pollack Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis Cancer Res., September 15, 2007; 67(18): 8504 - 8510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, J. Huang, N. Yang, J. Greshock, S. Liang, K. Hasegawa, A. Giannakakis, N. Poulos, A. O'Brien-Jenkins, D. Katsaros, et al. Integrative Genomic Analysis of Phosphatidylinositol 3'-Kinase Family Identifies PIK3R3 as a Potential Therapeutic Target in Epithelial Ovarian Cancer Clin. Cancer Res., September 15, 2007; 13(18): 5314 - 5321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Steger, T. Walles, T. Walker, and G. Friedel Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax Eur. Respir. J., September 1, 2007; 30(3): 598 - 599. [Full Text] [PDF]
|
|
|
|
|
|
W. L. Law, H. K. Choi, Y. M. Lee, and J. W. Ho The Impact of Postoperative Complications on Long-Term Outcomes Following Curative Resection for Colorectal Cancer Ann. Surg. Oncol., September 1, 2007; 14(9): 2559 - 2566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Liersch, J. Meller, M. Bittrich, B. Kulle, H. Becker, and D. M. Goldenberg Update of Carcinoembryonic Antigen Radioimmunotherapy with 131I-Labetuzumab After Salvage Resection of Colorectal Liver Metastases: Comparison of Outcome to a Contemporaneous Control Group Ann. Surg. Oncol., September 1, 2007; 14(9): 2577 - 2590. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rago, F. Santini, M. Scutari, A. Pinchera, and P. Vitti Elastography: New Developments in Ultrasound for Predicting Malignancy in Thyroid Nodules J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2917 - 2922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Mosley, J. T. Poirier, D. D. Seachrist, M. D. Landis, and R. A. Keri Rapamycin inhibits multiple stages of c-Neu/ErbB2 induced tumor progression in a transgenic mouse model of HER2-positive breast cancer Mol. Cancer Ther., August 1, 2007; 6(8): 2188 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A Kuehle, J. Langhorst, S. C Ladd, T. Zoepf, M. Nuefer, F. Grabellus, J. Barkhausen, G. Gerken, and T. C Lauenstein Magnetic resonance colonography without bowel cleansing: a prospective cross sectional study in a screening population Gut, August 1, 2007; 56(8): 1079 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Erythematous Papules and Plaques Involving the Groin and Scrotum Diagnosis Arch Dermatol, August 1, 2007; 143(8): 1067 - 1072. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Zhao, Y. Xiao, P. Elson, H. Tan, S. J. Plummer, M. Berk, P. P. Aung, I. C. Lavery, J. P. Achkar, L. Li, et al. Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer J. Clin. Oncol., July 1, 2007; 25(19): 2696 - 2701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Caron, G. Choquet-Kastylevsky, and R. Joubert-Caron Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery Mol. Cell. Proteomics, July 1, 2007; 6(7): 1115 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. Lane, G.Y.H. Lip, and D.G. Beevers Ethnic differences in cancer incidence and mortality: the Birmingham Factory Screening Project QJM, July 1, 2007; 100(7): 423 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lamy, S. Roussi, M. Chaabi, F. Gosse, N. Schall, A. Lobstein, and F. Raul Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis Carcinogenesis, July 1, 2007; 28(7): 1575 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Veit-Haibach, G Antoch, T Beyer, H Stergar, R Schleucher, E A M Hauth, and A Bockisch FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy Br. J. Radiol., July 1, 2007; 80(955): 508 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhu, G. Shi, C. Max. Schmidt, R. H. Hruban, and S. F. Konieczny Acinar Cells Contribute to the Molecular Heterogeneity of Pancreatic Intraepithelial Neoplasia Am. J. Pathol., July 1, 2007; 171(1): 263 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kiziltepe, T. Hideshima, L. Catley, N. Raje, H. Yasui, N. Shiraishi, Y. Okawa, H. Ikeda, S. Vallet, S. Pozzi, et al. 5-Azacytidine, a DNA methyltransferase inhibitor, induces ATR-mediated DNA double-strand break responses, apoptosis, and synergistic cytotoxicity with doxorubicin and bortezomib against multiple myeloma cells Mol. Cancer Ther., June 1, 2007; 6(6): 1718 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J-C Eymard, F Priou, A Zannetti, A Ravaud, D Lepille, P Kerbrat, P Gomez, B Paule, D Genet, P Herait, et al. Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancer Ann. Onc., June 1, 2007; 18(6): 1064 - 1070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tooker, W.-C. Yen, S.-C. Ng, A. Negro-Vilar, and T. W. Hermann Bexarotene (LGD1069, Targretin), a Selective Retinoid X Receptor Agonist, Prevents and Reverses Gemcitabine Resistance in NSCLC Cells by Modulating Gene Amplification Cancer Res., May 1, 2007; 67(9): 4425 - 4433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Welm, J. B. Sneddon, C. Taylor, D. S. A. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans PNAS, May 1, 2007; 104(18): 7570 - 7575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Giantonio, P. J. Catalano, N. J. Meropol, P. J. O'Dwyer, E. P. Mitchell, S. R. Alberts, M. A. Schwartz, and A. B. Benson III Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200 J. Clin. Oncol., April 20, 2007; 25(12): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|
